Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Fragoso Loyo, Hilda ^a   Cabiedes, Javier ^a   Orozco Narváez, Alejandro ^a   Dávila Maldonado, Luis ^a   Atisha Fregoso, Yemil ^a   Diamond, Betty ^b   Llorente, Luis ^a   Sánchez Guerrero, Jorge ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PREDNISONE; RIBOSOMAL P ANTIBODY; UNCLASSIFIED DRUG; BETA2 GLYCOPROTEIN 1; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RIBOSOME PROTEIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS; MALE; MENINGITIS; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; PREVALENCE; SERODIAGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; BRAIN VASCULITIS; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITALIZATION; IMMUNOLOGY; RETROSPECTIVE STUDY; SERUM; STATISTICS; TIME;

ADULT; ANTIBODIES; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; RECEPTORS, N-METHYL-D-ASPARTATE; RETROSPECTIVE STUDIES; RIBOSOMAL PROTEINS; SERUM; TIME FACTORS;

EID: 53749096519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003347     Document Type: Article

References (36)

1. Ruiz-Irastorza G, Khamashta MA, Castellano G, Hughes GR (2001) Systemic lupus erythematosus. Lancet 357: 1027-1032.
2. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, et al. (2002) Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 58: 1214-1220.
3. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K (2004) Neuropsychiatric Events in Systemic Lupus Erythematosus: Attribution and Clinical Significance. J Rheumatol 31: 2156-2162.
4. West SG, Emlen W, Wener MH, Kotzin BL (1995) Neuropsychiatric Lupus Erythematosus: A 10-year Prospective Study on the Value of Diagnostics Test. Am J Med 99: 153-163.
5. Hay EM, Isenberg DA (1993) Autoantibodies in Central Nervous System Lupus. Clinical review. Br J Rheumatol 32: 329-332.
6. Greenwood D, Gitlits VM, Alderuccio F, Sentry JW, Tho B (2002) Autoantibodies in Neuropsychiatric Lupus. Autoimmunity 35: 79-86.
7. Yoshio T, Onda K, Nara H, Minota S (2006) Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 54: 675-681.
8. Hanly JG, Rabichaud J, Fisk JD (2006) Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol 33: 1553-1558.
9. Bluestein HG, Williams GW, Steinberg AD (1981) Cerebrospinal fluid antibodies to neuronal cells: associations with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 70: 240-246.
10. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, et al. (1987) Association between lupus psychosis and anti-ribosomal P protein antibodies. N Eng J Med 317: 265-271.
11. Schneebaum AB, Singleton JD, Sterling GW, Blodgett JK, Allen LG, et al. (1991) Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 90: 54-62.
12. Isshi K, Hirohata SH (1998) Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 41: 1819-1827.
13. Toubi E, Kamashta MA, Panarra A, Hughes GR (1995) Association of antiphospholipid Abs with central nervous system disease in systemic lupus erythematosus. Am J Med 99: 397-401.
14. Herranz MT, River G, Kamashta MA, Blaser KU, Hughes G (1994) Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 37: 568-571.
15. Pereira RM, Yoshinari NH, De Oliveira RM, Cossermelli W (1992) Antiganglioside Abs in patients with neuropschyatric systemic lupus erythematosus. Lupus 1: 175-179.
16. Jennekens FGI, Kater L (2002) The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 41: 619-630.
17. Kowal C, DeGiorgio LA, Lee JY, Edgar MA, Huerta PT, et al. (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA 103: 19854-19859.
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277.
19. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29: 288-291.
20. Gladman DD, Ginzler E, Goldsmith C, Fortin P, Liang M, et al. (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39: 363-369.
21. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42: 599-608.
22. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57: 496-500.
23. Zandman-Goddard G, Chapman J, Shoenfeld Y (2007) Autoantibodies involved in neuropsychiatric SLE and Antiphospholipid Syndrome. Semin Arthritis Rheum 36: 297-315.
24. Correale J, Villa A (2007) The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting. Autoimmunity 40: 148-160.
25. Abbott NJ, Mendonca LL, Dolman DE (2003) The blood-brain barrier in systemic lupus erythematosus. Lupus. 12: 908-915.
26. Abdel-Rahman A, Shetty AK, Abou-Donia MB (2002) Disruption of the blood brain barrier and neuronal cell death in cingulated cortex, dentate gyrus, thalamus and hypothalamus in a rat model of Gulf-War syndrome. Neurobiol Dis 10: 306-326.
27. Esposito P, Chandler N, Kandere K, Basu S, Jacobson S, et al. (2002) Corticotropin-relasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 303: 1061-1066.
28. Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, et al. (2004) Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res 1027: 48-58.
29. Hawkins BT, Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57: 173-185.
30. Hanly JG, Noreen MG, Sangalang V (1992) Brain pathology in systemic lupus erythematosus. J Rheumatology 19: 732-741.
31. Devinsky O, Petito CK, Alonso DR (1988) Clinical and Neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 23: 380-384.
32. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narvaéz A, Dávila-Maldonado L, Athisa- Fregoso Y, et al. (2007) Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 56: 1242-1250.
33. Mikdashi J, Handwerger B (2004) Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 43: 1555-1560.
34. Appenzeller S, Rondina JM, Li LM, Costallat LT, Cendes F (2005) Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum 52: 2783-2789.
35. Kozora E, Arciniegas DB, Filley CM, Ellison MC, West SG, et al. (2005) Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol 18: 159-162.
36. Sánchez-Guerrero J, Aranow C, Mackay M, Volpe B, Diamond B (2008) Neuropsychiatric systemic lupus erythematosus reconsidered. Nat Clin Pract Rheumatol. 4: 112-113.